Herta Launches a New Technology That Allows Facial Identification Even With a Mask

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

Based on Deep Learning technology, Herta’s algorithms provide very high identification rates, especially in identity verification tasks and their reliability is very high, even when people hide a large part of their face. It is worth noting that the most differential part of the human face is in the eye region.

The launch of this software is key for automatic passenger identification systems, such as border control with the passport. This way it will not be necessary for the person to remove the mask, avoiding possible contagion or long waiting times. Its application, in general, extends to any type of access control or identity verification system.

Herta expects that the impact of this new technology in the market will be very important worldwide and that it will be massively used in environments such as transportation, health, government, events, sports stadiums or in the gaming sector.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.